NCT03353922View on ClinicalTrials.gov

Driving Simulation to Assess Non-Sedative Effects of Tolperisone

PHASE1CompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

July 31, 2017

Primary Completion Date

December 6, 2017

Study Completion Date

January 30, 2018

Conditions
Driving Impaired
Interventions
DRUG

Cyclobenzaprine 10 Mg Oral Tablet

cyclobenzaprine 10 mg tablets

DRUG

Placebo Oral Tablet

sugar pill

Trial Locations (2)

30342

NeuroTrials Research, Atlanta

92845

Collaborative Neuroscience Network, Long Beach

Sponsors
All Listed Sponsors
collaborator

Cognitive Research Corporation

INDUSTRY

lead

Neurana Pharmaceuticals, Inc.

INDUSTRY